HHS

Updates 11/18/21
Provider Relief Funds Update: Phase 4 Deadline, Phase 3 Reconsiderations

HHS has recently designated $25.5 billion for provider relief funding.

Copyright Lument 2022

ORIX Real Estate Capital Holdings, LLC, d/b/a Lument, is a subsidiary of ORIX Corporation USA. *Securities, Investment Banking and Advisory Services provided through OREC Securities, LLC, d/b/a Lument Securities, Member FINRA/SIPC. Investment advisory services are provided by OREC Investment Management, LLC, d/b/a Lument Investment Management. OREC Investment Management is registered as an investment adviser with the U.S. Securities and Exchange Commission.